Skip to main content

Ruzurgi (amifampridine) Tablets by Jacobus Pharmaceutical Company

Sep 15, 2021

Jacobus Pharmaceutical Company Inc. Issues Voluntary Worldwide Recall of RuzurgiĀ® (amifampridine) 10 mg Tablets Due to Yeast, Mold, and Bacterial Contamination.

More on the FDA website.